FREE Case Review (866) 588-0600

Lipitor Diabetes Litigation Moving Forward

As Lipitor Lawsuits continued to be filed on behalf of women who allegedly developed type 2 diabetes after taking the drug, the federal litigation is moving forward with discovery, as the parties have recently agreed on forms to help with the exchange of information. In February of 2014, a multidistrict litigation (MDL) was formed to centralize all federal Lipitor Diabetes Lawsuits before a single judge for pretrial handling. In addition to type 2 diabetes, Lipitor has been linked to muscle damage, myopathy, kidney damage, liver failure, rhabdomyolysis, memory loss, and death.

Free Lipitor Lawsuit Evaluation: If you or a loved one was diagnosed with type 2 diabetes after taking Lipitor, you should contact our law firm immediately. You may be entitled to compensation by filing a suit against the manufacturer of Lipitor and we can help.

Lipitor Multidistrict Litigation

The Lipitor Multidistrict Litigation has been consolidated before Judge Richard K. Gergel in the District of South Carolina. The lawsuits allege that Pfizer failed to adequately warn about the diabetes risk associated with Lipitor, and claim that the plaintiffs never would have used the drug if accurate warnings had been provided. MDLs are formed to reduce duplicative discovery, avoid conflicting rulings from different judges, and to serve the convenience of all parties involved in the litigation.

At the time the Lipitor MDL was established in February 2014, there were approximately 56 cases pending in the federal court system. Since then, the litigation has grown to include more than 600 Lipitor Lawsuits.

Discovery Process

Judge Gergel is working to establish a discovery plan for selecting a small group of lawsuits that will be prepared for early trial dates called “bellwether” claims, since the outcomes are intended to help gauge how juries may respond to evidence and testimony that is likely to be presented repeatedly during the litigation. In May 2014, a Plaintiffs’ Fact Sheet was created to facilitate the exchange of information about each case. Each plaintiff in the MDL has been directed to provide Pfizer with the fact sheet, authorizations, medical records and other required documents by June 2nd. For all future cases that have yet to be filed, the fact sheet must be provided within one month of the case being included in the MDL.

Lipitor and Diabetes

Each of the lawsuits alleges that Pfizer knew – or should have known – about the link between Lipitor and type 2 diabetes, yet the company withheld this information from the public while turning the drug into one of the most widely-prescribed brand names in America. Lipitor uses the liver to inhibit the production of cholesterol, which is a contributor to coronary artery disease (CAD). However, recent studies have linked Lipitor and other similar drugs to an increased risk for life-threatening injuries including diabetes, muscle damage, kidney problems, rhabdomyolysis and liver failure.

Do I Have a Lipitor Type 2 Diabetes Lawsuit?

The Product Liability & Defective Drug Litigation Group at our law firm is an experienced team of trial lawyers that focus on the representation of plaintiffs in Lipitor lawsuits. We are handling individual litigation nationwide and currently accepting new Lipitor type 2 diabetes cases in all 50 states.

Free Lipitor Lawsuit Evaluation: If you or a loved one was diagnosed with type 2 diabetes after taking Lipitor, you should contact our law firm immediately. You may be entitled to compensation by filing a Lipitor type 2 diabetes suit and we can help.

Free Confidential Case Evaluation

Verified 100% Secure SiteTo contact us for a free review of your potential case, please fill out the form below or call us toll free 24 hrs/day by dialing: (866) 588-0600.
*
*
*
Awards & recognition